Literature DB >> 3827215

Tobacco-induced primary-position upbeat nystagmus.

P A Sibony, C Evinger, K A Manning.   

Abstract

The effects of tobacco smoking on the eye movements of normal human subjects were studied using direct current electrooculography and the magnetic search coil technique. Tobacco induced a transient primary-position upbeat nystagmus in the dark, which was suppressed by visual fixation. It obeyed Alexander's law and was associated with oblique upward fast phases that alternated from side to side. Tobacco-induced nystagmus exhibited a latency of onset at 40 to 90 seconds, a duration of 10 to 20 minutes, and maximum slow-phase velocities at 2 to 3 minutes. We suggest that tobacco induces primary-position upbeat nystagmus through the excitatory effects of nicotine on the central vestibular pathways.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827215     DOI: 10.1002/ana.410210110

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

1.  A pharmacological distinction between the long and short latency pathways of the human blink reflex revealed with tobacco.

Authors:  C Evinger; P A Sibony; K A Manning; R A Fiero
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

2.  The effect of nicotine on perceptual, ocular motor, postural, and vegetative functions at rest and in motion.

Authors:  V C Zingler; K Denecke; K Jahn; L von Meyer; S Krafczyk; M Krams; R Elfont; T Brandt; M Strupp; S Glasauer
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

3.  Upbeat nystagmus: clinicoanatomical correlations in 15 patients.

Authors:  Ji Soo Kim; Bora Yoon; Kwang-Dong Choi; Sun-Young Oh; Seong-Ho Park; Byung-Kun Kim
Journal:  J Clin Neurol       Date:  2006-03-20       Impact factor: 3.077

4.  The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus.

Authors:  M Dieterich; A Straube; T Brandt; W Paulus; U Büttner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.